Type I interferons in anticancer immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type I interferons in anticancer immunity

Published:2015-06-01 Issue:7 Volume:15 Page:405-414
ISSN:1474-1733
Container-title:Nature Reviews Immunology
language:en
Short-container-title:Nat Rev Immunol

Author:

Zitvogel Laurence,Galluzzi Lorenzo,Kepp Oliver,Smyth Mark J.,Kroemer Guido

Publisher

Springer Science and Business Media LLC

Subject

Energy Engineering and Power Technology,Fuel Technology

Link

http://www.nature.com/articles/nri3845.pdf

Reference124 articles.

1. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147, 258–267 (1957). In this report, type I IFN was described for the first time as a factor released by chick chorioallantoic membranes upon exposure to heat-inactivated influenza viruses, which could be used to interfere with the replication of live viruses of the same type.

2. Trinchieri, G. Type I interferon: friend or foe? J. Exp. Med. 207, 2053–2063 (2010).

3. Kaur, S. & Platanias, L. C. IFN-β-specific signaling via a unique IFNAR1 interaction. Nat. Immunol. 14, 884–885 (2013).

4. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384 (2010).

5. Hervas-Stubbs, S. et al. Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 17, 2619–2627 (2011).

Cited by 1001 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer;Current Medicinal Chemistry;2024-12

2. cGAS/STING signalling pathway in senescence and oncogenesis;Seminars in Cancer Biology;2024-11

3. Engineering interferons for cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

4. Study on the Recombinant Human Interferon α1b, α2b, and Gamma Transient Expression and in Vitro Activities in Tobacco;Journal of Interferon & Cytokine Research;2024-09-13

5. N‐Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL‐1β Productions for Antitumor Immunity.;Advanced Functional Materials;2024-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3